Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 3 9Phase NA 6Phase 2/3 5Phase 1 3Phase 1/2 2Phase EARLY_PHASE1 1Phase 4 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Quality of Life 1Breast Neoplasms 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Melatonin × Clear all
NCT07067307 2025-07-16

Melatonin in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Mansoura University

Phase 1/2 Not yet recruiting
80 enrolled
Breast

Breast Neoplasms

NCT02486796 2018-08-01

Immediate or Delayed Naturopathic Medicine in Combination With Neo-Adjuvant Chemotherapy for Breast Cancer

Midwestern Regional Medical Center

Phase 1/2 Terminated
5 enrolled 8 charts

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon âš¡